IP Strategy

Definition

IP (Intellectual Property) strategy is a systematic plan for identifying, protecting, managing, and leveraging a company's intellectual assets — patents, trademarks, trade secrets, copyrights, and design rights — to support business objectives. An effective strategy aligns protection mechanisms with the business model, competitive landscape, and risk tolerance. [src1] The choice between formal protection (patents) and informal protection (trade secrets, lead time) depends on the innovation's nature, detectability, and competitive environment. [src3]

Key Properties

Patent: 20-year exclusivity in exchange for public disclosure; strongest for reverse-engineerable innovations [src3]
Trade secret: Unlimited duration but requires active secrecy measures; preferred when independent discovery is unlikely [src4]
Trademark: Protects brand identifiers; renewable indefinitely; critical for consumer brands [src1]
Open-source policy: Governs OSS usage/contribution; must address license compatibility (permissive vs. copyleft) [src2]
IP audit: Systematic inventory of all IP assets — foundational input for strategy [src5]

Constraints

Patent protection varies by jurisdiction — PCT deadlines (30-31 months) are hard cutoffs. [src1]
Trade secret protection requires documented secrecy measures — courts deny status without evidence of NDAs, access controls. [src4]
Copyleft licenses (GPL, AGPL) require derivative works to be open-sourced, potentially exposing proprietary code. [src2]
IP strategy must align with business model — defensive patents for hardware, trade secrets for SaaS. [src3]
AI-generated inventions present unresolved legal questions in most jurisdictions. [src2]

Framework Selection Decision Tree

START — User needs IP protection guidance
├── What type of innovation?
│   ├── Technical invention
│   │   ├── Reverse-engineerable? → Patent
│   │   └── Not discoverable? → Trade secret
│   ├── Brand identity → Trademark registration
│   ├── Creative work → Copyright
│   └── Software with OSS → Open-source policy
├── Business model?
│   ├── Hardware/manufacturing → Strong patent portfolio
│   ├── SaaS/services → Trade secrets + speed-to-market
│   ├── Platform → Trademark + defensive patents
│   └── Open-source business → Trademark + CLAs
└── Company stage?
    ├── Startup → Trademark, key trade secrets, 1-3 strategic patents
    ├── Growth → Expand portfolio, OSS policy, FTO reviews
    └── Mature → Portfolio optimization, licensing, M&A due diligence

Application Checklist

Step 1: Conduct IP audit

Inputs needed: Product inventory, invention disclosures, registrations, OSS usage log
Output: Comprehensive IP asset register
Constraint: Include negative space — identify unprotected innovations and assess whether protection is still possible [src5]

Step 2: Align strategy with business model

Inputs needed: Business model, competitive analysis, revenue strategy
Output: IP strategy document mapping each asset type to objectives
Constraint: IP supports the business, not the other way around — do not patent for vanity [src2]

Step 3: Implement protection mechanisms

Inputs needed: Strategy, budget, legal counsel
Output: Filed applications, trade secret protocols, OSS policy
Constraint: Patent filing triggers 12-month priority period — plan international filings early [src1]

Step 4: Establish ongoing governance

Inputs needed: IP portfolio, tech roadmap, employee agreements
Output: IP review process, OSS approval workflow, annual portfolio review
Constraint: Employee IP assignment agreements must be in place before work begins [src5]

Anti-Patterns

Wrong: Patenting everything without strategic purpose

Filing 50 patents for portfolio count while they do not align with products, licensing, or defense. Maintenance fees accumulate with no return. [src2]

Correct: Selective patenting aligned with business value

File patents that protect revenue-generating products, enable licensing, or provide defensive value. Abandon patents that no longer serve objectives. [src1]

Wrong: Using open-source without tracking licenses

No SBOM, no license checks. Copyleft component discovered during M&A due diligence threatens the deal. [src2]

Correct: OSS policy with automated compliance

Pre-approval for copyleft, maintained SBOM, automated scanning tools (FOSSA, Snyk, Black Duck). [src5]

Wrong: Trade secrets without documentation

Claiming trade secret status but having no NDAs, access controls, or exit procedures. Court finds no trade secret exists. [src4]

Correct: Document and enforce secrecy measures

Trade secret register, need-to-know access, NDAs, marked materials, exit interviews. All measures documented for legal defensibility. [src4]

Common Misconceptions

Misconception: Patents are always stronger than trade secrets.
Reality: Patents require public disclosure and last 20 years. Trade secrets can last indefinitely without disclosure. For non-reverse-engineerable innovations, trade secrets may be stronger. [src3]

Misconception: Open-source software is free with no obligations.
Reality: OSS licenses impose legal obligations — attribution (MIT, Apache), copyleft (GPL, AGPL), patent grants. Using without understanding terms creates liability. [src2]

Misconception: IP strategy is only for large companies.
Reality: Every company has IP — brand names, algorithms, customer lists, code. Even startups need trademark strategy and employee IP assignment agreements. [src1]

Comparison with Similar Concepts

Concept	Key Difference	When to Use
Patent	Public disclosure for 20-year exclusivity	Reverse-engineerable innovations
Trade Secret	Secrecy-based, unlimited duration	Non-discoverable innovations
Trademark	Brand identity protection, renewable	Consumer-facing brands and products
Copyright	Automatic protection for creative expression	Software, content, design works
Open-Source Policy	Governance of OSS usage/contribution	Companies using or contributing to OSS

When This Matters

Fetch this when a user asks about IP strategy, patent vs. trade secret decisions, open-source compliance, IP portfolio management, or protecting innovations at different stages. Also relevant for M&A due diligence and licensing negotiations.